Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
9.98
+0.06 (0.60%)
At close: Aug 1, 2025, 4:00 PM
10.03
+0.05 (0.50%)
After-hours: Aug 1, 2025, 7:53 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$34.00
Upside
+240.68%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $37 → $35 | Strong Buy | Maintains | $37 → $35 | +250.70% | Jul 15, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +80.36% | Jul 10, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +70.34% | May 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +220.64% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $41 | Buy | Maintains | $39 → $41 | +310.82% | Mar 20, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $35 → $39 | Buy | Maintains | $35 → $39 | +290.78% | Mar 4, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $42 | Strong Buy | Maintains | $45 → $42 | +320.84% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +411.02% | Mar 4, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +60.32% | Jan 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +411.02% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +280.76% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $37 → $45 | Strong Buy | Maintains | $37 → $45 | +350.90% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $49 → $51 | Strong Buy | Maintains | $49 → $51 | +411.02% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $49 | Strong Buy | Maintains | $47 → $49 | +390.98% | Nov 12, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $30 → $33 | Strong Buy | Maintains | $30 → $33 | +230.66% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $47 | Strong Buy | Maintains | $45 → $47 | +370.94% | Nov 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.